Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 341360 of 20,252 grants

Active OTHER RESEARCH-RELATED
Enhancement and further development of informatics methods for long-read cancer sequencing
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Project Summary Long-read sequencing is rapidly transforming our knowledge of the human genome as well as the approach to uncovering human genetic variation and alterations. In con...

$8.73M
USD
Active OTHER RESEARCH-RELATED
Tumor-cell intrinsic and extrinsic determinants of drug resistance and metastasis
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2024 – 2026

PROJECT SUMMARY Despite advances in cancer therapy, metastatic disease is overwhelmingly fatal and accounts for most cancer- related deaths. Systemic therapies fail to control diss...

$386.9K
USD
Active TRAINING, INDIVIDUAL
Comparative analysis of M-CSF and GM-CSF in human monocyte metabolic reprogramming and differentiation into tumor-associated macrophage-like cells
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2027

PROJECT SUMMARY A major component of the tumor microenvironment, tumor-associated macrophages (TAMs) play a critical role in the orchestration of immunosuppression, cancer cell pro...

$539.7K
USD
Active TRAINING, INDIVIDUAL
Promoting Activated Natural Killer (NK) Cell Accumulation in Pancreatic Cancer
NATIONAL CANCER INSTITUTE Georgetown University United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, with a 5-year survival rate of only 12%. Immunotherapy, such as anti-...

$362.7K
USD
Active NON-SBIR/STTR RPGS
Investigating DNA polymerase O in replication stress and cancer therapy
NATIONAL CANCER INSTITUTE Scripps Research Institute, The United States 2024 – 2029

Principal Investigator: Wu, Xiaohua Project Summary Replication stress often occurs when DNA replication is disrupted, leading to DNA double-strand break (DSB) formation. Replicati...

$6.07M
USD
Active OTHER RESEARCH-RELATED
Dissecting intrinsic variability in engineered T Cell immunotherapies
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Cancer immunotherapy has revolutionized oncology. Chimeric Antigen Receptor (CAR) T cells in particular have shown dramatic successes in some liquid tumors...

$3.31M
USD
Active TRAINING, INDIVIDUAL
Investigating the regulation of cancer cell death by NFE2L1
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2026

Project Summary Resistance to therapy is responsible for 90% of cancer patient mortality. Our understanding of how cancer cells resist therapy-induced death is limited. My goal is...

$424.7K
USD
Active NON-SBIR/STTR RPGS
Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2029

SUMMARY/ABSTRACT Breast cancer is a leading cause of death in the U.S. and a major public health burden as one woman out of eight will receive a diagnosis in her lifetime. Advances...

$8.73M
USD
Active OTHER RESEARCH-RELATED
Ceramide and Cell Metabolism: Defining the Role of Sphingolipids in Modulating Mitochondrial Bioenergetics of Chronic Lymphocytic Leukemia
NATIONAL CANCER INSTITUTE University of Virginia United States 2024 – 2026

Project Summary/Abstract Chronic lymphocytic leukemia (CLL) is the most common form of adult leukemia and accounts for 20% of leukemia-related deaths annually. In CLL, hyperactivat...

$397K
USD
Active OTHER RESEARCH-RELATED
Resolving epigenetic determinants of cellular plasticity programs in non-small cell lung cancer
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2026

SUMMARY Pioneering research in cancer biology over the past four decades has uncovered a repertoire of oncogenes and tumor suppressors that initiate and maintain tumorigenesis acro...

$435.5K
USD
Active NON-SBIR/STTR RPGS
Evaluating and Optimizing Novel nSMase2 Inhibitors in the Treatment of Cancers
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT ABSTRACT / SUMMARY: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but many patients fail to respond. Expanding the response to ICIs is a major g...

$6.96M
USD
Active OTHER RESEARCH-RELATED
Determinants of susceptibility to pediatric acute myeloid leukemia
NATIONAL CANCER INSTITUTE Van Andel Research Institute United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT The role of germline genetic variation and viral infection in development and progression has been studied extensively in adult tumors and autoimmune disea...

$494.7K
USD
Active OTHER RESEARCH-RELATED
The alterations caused by obese extracellular vesicles on colorectal cancer tumor microenvironment
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2026

Project Summary Colorectal cancer (CRC) patients with a high body-mas index (BMI) have poor efficacy to chemotherapy, creating an urgent need to design targeted therapy for this gr...

$398.7K
USD
Active NON-SBIR/STTR RPGS
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2024 – 2029

ABSTRACT - The focus of this proposal is on lethal, metastatic prostate cancer (PC). The aim of this study is to develop an innovative, minimally invasive, liquid biopsy assay that...

$6.49M
USD
Active OTHER RESEARCH-RELATED
Investigating the molecular signatures and pathways indicative of air pollution toxicity in lung carcinogenesis using single- and multi-omics analyses of genomics, proteomics, and metabolomics
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2026

Project Summary Air pollution is a known environmental risk factor for lung cancer, but the detailed mechanisms driving air pollution-induced carcinogenesis and the key molecular e...

$504.7K
USD
Active NON-SBIR/STTR RPGS
Informatics strategies to improve immune-related adverse event detection in cancer patients
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Immune checkpoint inhibitors (ICIs) have drastically improved cancer survival over the past decade, but this survival comes at the cost of a new class of i...

$4.6M
USD
Active OTHER RESEARCH-RELATED
Understanding expression and signaling of sex hormone receptors in brain cancers
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2026

PROJECT SUMMARY There is significant evidence of cancer-type specific patterns of sex hormone receptor expression and signaling in many central nervous system (CNS) tumors, often c...

$487.2K
USD
Active OTHER RESEARCH-RELATED
Microbiome-Mitochondrial Interactions Driving Cancer-Induced Cachexia in the Obese State
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2024 – 2026

PROJECT SUMMARY Research: At the time of cancer diagnosis, 40% - 60% of patients are overweight or obese. Despite this, there is a dearth of literature on the impact of weight stat...

$402K
USD
Active NON-SBIR/STTR RPGS
Intersection of cytoskeletal regulation with tumor cell metabolism
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

SUMMARY Pancreatic cancer (PDAC) is particularly lethal, due in part to a resistance to therapies and a high incidence of metastasis. The overall goal of our research program is to...

$4.29M
USD
Active NON-SBIR/STTR RPGS
Defining pro-metastatic drivers in the pancreatic cancer tumor microenvironment
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT ABSTRACT Pancreatic adenocarcinoma (PDAC) is an almost uniformly fatal disease most often diagnosed after the development of metastases. The tumor suppressor gene, TP53, is...

$4.53M
USD